68
Participants
Start Date
October 31, 2005
Primary Completion Date
August 31, 2006
Study Completion Date
October 31, 2006
Clobazam Low Dose
5 to 10 mg/day with doses in the morning and at bedtime; orally
Clobazam High Dose
5 to 40 mg/day with doses in the morning and at bedtime; orally
Children's National Medical Center, Washington D.C.
Virginia Commonwealth University, Richmond
Monarch Medical Research, Norfolk
Pediatric Epilepsy & Neurology Specialists, Tampa
University of Tennessee Health Science Center, Memphis
Children's Hospital, Columbus
Children's Hospital of Wisconsin, Milwaukee
Minnesota Epilepsy Group, P.A., Saint Paul
Texas Child Neurology, LLP, Plano
Dallas Pediatric Neurology Associates, Dallas
Barrow Neurological Institute, Phoenix
Childrens Hospital Los Angeles, Los Angeles
Massachusetts General Hospital, Boston
Childrens Hospital Boston, Boston
Lead Sponsor
Lundbeck LLC
INDUSTRY